Tubulis, a Germany-based biotech that develops ADCs for solid and hematologic tumours, has closed a €308m (US$358m) Series C financing led by Venrock Healthcare Capital Partners with participation from additional…
Germany: Tubulis raises €308m Series C to expand clinical development of lead ADC candidate
…
…






